BioNTech and OncoC4 report gotistobart nearly doubles median overall survival in squamous lung cancer Phase 3
Read more: BioNTech, 14 September 2026 · Reuters, 14 September 2026
Read more: BioNTech, 14 September 2026 · Reuters, 14 September 2026